NASDAQ:GNOM - Complete Genomics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$14.10 -0.08 (-0.56 %)
(As of 04/22/2019 02:46 AM ET)
Previous Close$14.1050
Today's Range$13.92 - $14.27
52-Week Range$13.92 - $15.39
Volume11,306 shs
Average Volume21,801 shs
Market Capitalization$2.12 million
P/E RatioN/A
Dividend Yield0.00%
Complete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.

Receive GNOM News and Ratings via Email

Sign-up to receive the latest news and ratings for GNOM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Current SymbolNASDAQ:GNOM



Sales & Book Value

Annual SalesN/A



Market Cap$2.12 million
Next Earnings DateN/A
OptionableNot Optionable

Complete Genomics (NASDAQ:GNOM) Frequently Asked Questions

What is Complete Genomics' stock symbol?

Complete Genomics trades on the NASDAQ under the ticker symbol "GNOM."

Has Complete Genomics been receiving favorable news coverage?

News headlines about GNOM stock have trended somewhat positive this week, according to InfoTrie Sentiment. The research group rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Complete Genomics earned a media sentiment score of 1.2 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future.

What other stocks do shareholders of Complete Genomics own?

How do I buy shares of Complete Genomics?

Shares of GNOM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Complete Genomics' stock price today?

One share of GNOM stock can currently be purchased for approximately $14.1050.

How big of a company is Complete Genomics?

Complete Genomics has a market capitalization of $2.12 million.

What is Complete Genomics' official website?

The official website for Complete Genomics is

How can I contact Complete Genomics?

Complete Genomics' mailing address is 2071 Stierlin Ct, MOUNTAIN VIEW, CA 94043-4655, United States. The company can be reached via phone at +1-650-9432800.

MarketBeat Community Rating for Complete Genomics (NASDAQ GNOM)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  155 (Vote Outperform)
Underperform Votes:  151 (Vote Underperform)
Total Votes:  306
MarketBeat's community ratings are surveys of what our community members think about Complete Genomics and other stocks. Vote "Outperform" if you believe GNOM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNOM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/22/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel